Article
A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients.
Psychological medicine - 1 Jun 2006
Joyce Peter R, McHugh Patrick C, McKenzie Janice M, Sullivan Patrick F, Mulder Roger T, Luty Suzanne E, Carter Janet D, Frampton Christopher M A, Robert Cloninger C, Miller Allison M, Kennedy Martin A
Abstract excerpt
BACKGROUND: Borderline personality disorder (BPD) is often co-morbid with major depression and may complicate its treatment. We were interested in differences in genetic and developmental risk factors between depressed patients with or without a co-morbid BPD. METHOD: Out-patients with major depressive disorder were recruited for two treatment trials. Assessment of depressed patients included the assessment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
